Total Payments
$12,286
2024 Payments
$2,037
Companies
74
Transactions
822
Medicare Patients
4,146
Medicare Billing
$387,261
Payment Breakdown by Category
Food & Beverage$12,233 (99.6%)
Education$52.84 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,233 | 816 | 99.6% |
| Education | $52.84 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,851 | 250 | $0 (2024) |
| Novo Nordisk Inc | $1,187 | 76 | $0 (2024) |
| Merck Sharp & Dohme LLC | $838.32 | 59 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $603.77 | 31 | $0 (2024) |
| GlaxoSmithKline, LLC. | $531.25 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $527.40 | 22 | $0 (2021) |
| ABBVIE INC. | $522.97 | 37 | $0 (2024) |
| Lilly USA, LLC | $418.34 | 29 | $0 (2024) |
| PFIZER INC. | $365.58 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $323.24 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,037 | 115 | Amgen Inc. ($325.98) |
| 2023 | $1,744 | 109 | Amgen Inc. ($371.60) |
| 2022 | $1,748 | 120 | Novo Nordisk Inc ($304.09) |
| 2021 | $1,375 | 99 | Amgen Inc. ($284.74) |
| 2020 | $1,137 | 90 | Amgen Inc. ($399.18) |
| 2019 | $1,581 | 116 | Amgen Inc. ($539.63) |
| 2018 | $1,468 | 101 | Amgen Inc. ($459.43) |
| 2017 | $1,196 | 72 | AstraZeneca Pharmaceuticals LP ($202.36) |
All Payment Transactions
822 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes Care | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $103.83 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.49 | General |
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: LIVER DISEASE | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: PAIN | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.75 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,066 | 1,498 | $365,220 | $79,631 |
| 2022 | 15 | 1,069 | 1,483 | $347,850 | $74,141 |
| 2021 | 13 | 962 | 1,296 | $303,430 | $123,980 |
| 2020 | 18 | 1,049 | 1,372 | $303,020 | $109,510 |
Total Patients
4,146
Total Services
5,649
Medicare Billing
$387,261
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 705 | $169,285 | $27,913 | 16.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 57 | 57 | $22,515 | $15,798 | 70.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 161 | 186 | $60,450 | $11,959 | 19.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 179 | 179 | $70,705 | $9,245 | 13.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 58 | 58 | $5,220 | $4,100 | 78.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 67 | 67 | $4,690 | $2,276 | 48.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 59 | 59 | $4,130 | $2,004 | 48.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $8,400 | $1,937 | 23.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,520 | $1,641 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 29 | $4,785 | $1,504 | 31.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 100 | 103 | $6,180 | $982.50 | 15.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 16 | $1,120 | $198.44 | 17.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 12 | $2,220 | $72.89 | 3.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 324 | 713 | $171,120 | $31,015 | 18.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 137 | 153 | $49,725 | $10,265 | 20.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 172 | 172 | $67,940 | $9,364 | 13.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 32 | 32 | $5,760 | $4,240 | 73.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 51 | 51 | $4,590 | $3,496 | 76.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 83 | 83 | $5,810 | $2,799 | 48.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $4,345 | $2,781 | 64.0% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 30 | 30 | $2,700 | $2,050 | 75.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $7,280 | $2,034 | 27.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $8,120 | $1,893 | 23.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 49 | 49 | $3,430 | $1,670 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $3,300 | $1,083 | 32.8% |
About Gerald Lee
Gerald Lee is a Internal Medicine healthcare provider based in Harrington Park, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982692745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gerald Lee has received a total of $12,286 in payments from pharmaceutical and medical device companies, with $2,037 received in 2024. These payments were reported across 822 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($12,233).
As a Medicare-enrolled provider, Lee has provided services to 4,146 Medicare beneficiaries, totaling 5,649 services with total Medicare billing of $387,261. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Harrington Park, NJ
- Active Since 10/06/2005
- Last Updated 01/11/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982692745
Products in Payments
- Aimovig (Biological) $795.75
- Otezla (Drug) $682.53
- Prolia (Biological) $611.11
- EVENITY (Biological) $517.30
- XARELTO (Drug) $472.71
- FARXIGA (Drug) $470.37
- JANUVIA (Drug) $469.99
- Ozempic (Drug) $327.22
- JARDIANCE (Drug) $315.79
- Rybelsus (Drug) $271.39
- TRELEGY ELLIPTA (Drug) $240.77
- Wegovy (Drug) $228.39
- Repatha (Biological) $227.16
- REXULTI (Drug) $211.42
- LINZESS (Drug) $211.13
- MOUNJARO (Drug) $192.09
- SHINGRIX (Biological) $174.74
- WATCHMAN Access System (Device) $144.43
- NURTEC ODT (Drug) $138.39
- UBRELVY (Drug) $135.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Harrington Park
John Hwang
Internal Medicine — Payments: $45,343
Internal Medicine $45,343
Nidhi Narayan, M.d, M.D
Internal Medicine — Payments: $15,233
Internal Medicine $15,233
Dr. Walter Klein, M.d, M.D
Internal Medicine — Payments: $8,248
Internal Medicine $8,248
Peter Symington
Internal Medicine — Payments: $7,143
Internal Medicine $7,143
Tina Fadil
Internal Medicine — Payments: $5,405
Internal Medicine $5,405
Dr. Joanna Blanco, M.d, M.D
Internal Medicine — Payments: $4,045
Internal Medicine $4,045